User profiles for Stephen N. Floor
Stephen N. FloorDeveloping RNA Technologies @ Inceptive Verified email at inceptive.team Cited by 6779 |
[HTML][HTML] A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
A newly described coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
which is the causative agent of coronavirus disease 2019 (COVID-19), has …
which is the causative agent of coronavirus disease 2019 (COVID-19), has …
Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes
…, C Coulon-Bainier, AA Banfal, SN Floor… - Nature …, 2017 - nature.com
We demonstrate editing of post-mitotic neurons in the adult mouse brain following injection
of Cas9 ribonucleoprotein (RNP) complexes in the hippocampus, striatum and cortex. …
of Cas9 ribonucleoprotein (RNP) complexes in the hippocampus, striatum and cortex. …
Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor
Rocaglamide A (RocA) typifies a class of protein synthesis inhibitors that selectively kill
aneuploid tumour cells and repress translation of specific messenger RNAs 1 , 2 , 3 , 4 . RocA …
aneuploid tumour cells and repress translation of specific messenger RNAs 1 , 2 , 3 , 4 . RocA …
Tunable protein synthesis by transcript isoforms in human cells
10.7554/eLife.10921.001 Eukaryotic genes generate multiple RNA transcript isoforms though
alternative transcription, splicing, and polyadenylation. However, the relationship between …
alternative transcription, splicing, and polyadenylation. However, the relationship between …
CRISPR–Cas9 genome editing in human cells occurs via the Fanconi anemia pathway
CRISPR–Cas genome editing creates targeted DNA double-strand breaks (DSBs) that are
processed by cellular repair pathways, including the incorporation of exogenous DNA via …
processed by cellular repair pathways, including the incorporation of exogenous DNA via …
[PDF][PDF] The translation inhibitor rocaglamide targets a bimolecular cavity between eIF4A and polypurine RNA
…, A Sakamoto, C Watanabe, Y Shichino, SN Floor… - Molecular cell, 2019 - cell.com
A class of translation inhibitors, exemplified by the natural product rocaglamide A (RocA),
isolated from Aglaia genus plants, exhibits antitumor activity by clamping eukaryotic translation …
isolated from Aglaia genus plants, exhibits antitumor activity by clamping eukaryotic translation …
[PDF][PDF] Pathogenic DDX3X mutations impair RNA metabolism and neurogenesis during fetal cortical development
…, G Mirzaa, C Mignot, N Miyake, N Matsumoto… - Neuron, 2020 - cell.com
De novo germline mutations in the RNA helicase DDX3X account for 1%–3% of unexplained
intellectual disability (ID) cases in females and are associated with autism, brain …
intellectual disability (ID) cases in females and are associated with autism, brain …
[PDF][PDF] Widespread translational remodeling during human neuronal differentiation
Faithful cellular differentiation requires temporally precise activation of gene expression
programs, which are coordinated at the transcriptional and translational levels. Neurons express …
programs, which are coordinated at the transcriptional and translational levels. Neurons express …
[PDF][PDF] mRNA decapping is promoted by an RNA-binding channel in Dcp2
…, BN Jones, DU Quang-Dang, J Flinders, SN Floor… - Molecular cell, 2008 - cell.com
Cap hydrolysis by Dcp2 is a critical step in several eukaryotic mRNA decay pathways.
Processing requires access to cap-proximal nucleotides and the coordinated assembly of a …
Processing requires access to cap-proximal nucleotides and the coordinated assembly of a …
Aberrant cortical development is driven by impaired cell cycle and translational control in a DDX3X syndrome model
Mutations in the RNA helicase, DDX3X, are a leading cause of Intellectual Disability and
present as DDX3X syndrome, a neurodevelopmental disorder associated with cortical …
present as DDX3X syndrome, a neurodevelopmental disorder associated with cortical …